糖尿病性ストライアパシー:ケースシリーズと文献の合成から得られた認知と行動に関する洞察
Souvik Dubey1, Subhankar Chatterjee2, Ritwik Ghosh3
1Department of Neuromedicine, Bangur Institute of Neurosciences, IPGMER & SSKM Hospital, Kolkata, India.
まとめ
糖尿病性ストライアポサティ (DS) は,運動障害だけでなく,認知および行動の変化を引き起こす可能性があります. 患者は,様々な認知障害やうつ病などの行動障害を示しており,これは,運動症状を超えてDSの影響を示唆している.
科学分野:
- 神経科学は神経科学である.
- 神経学 神経学とは
- エンドクリノロジー エンドクリノロジー
背景:
- ストレイタル障害は,しばしば認知および運動障害につながる.
- 珍しい糖尿病合併症である糖尿病性ストライアポシ (DS) は,通常,運動障害に関連しています.
- DSの認知行動的側面については,さらなる調査が必要である.
研究 の 目的:
- 糖尿病性ストライアパシー患者の認知および行動プロフィールを調査する.
- DSが運動機能と認知行動機能に及ぼす様々な影響の背後にあるメカニズムを探求する.
主な方法:
- DSとヘミコリアのベンガルの患者5人は,発症から3ヶ月後に神経心理学的評価 (MoCA, ACE-III, FAB) と行動評価 (NPI) を受けました.
- 文献のレビューでは,認知行動的表れを持つDSの5つの以前の症例を特定しました.
主要な成果:
- 患者は (女性3人,男性2人,平均年齢69.7歳) 糖尿病のコントロールが悪かった.
- 認知欠陥には,注意力,実行機能,最近の記憶,言語障害が含まれていました.
- 行動的問題は,精神病のない鬱,無関心,強迫的行動を含む. 視覚空間的機能は保たれた.
結論:
- DSは,他のストライタル障害と比較して,より軽度の認知行動障害を呈することがあります.
- このプロファイルは,選択回路の関与,補償メカニズム,急性病理,および潜在的な可逆性から生じる可能性があります.
- 発見は,DSの理解を,その運動症状を超えて広げています.
キーワード:
MRIハイパーインテンシティー基礎ギャングリアコグニティブ障害 (Cognitive Impairment) とは,認知機能の低下による糖尿病性ストライアポサシー (糖尿病性ストライアポサシー)ハイパーグリセミア (高血糖症)精神疾患 精神疾患とはさらに関連する動画
関連する概念動画
Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
462
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
462
Chronic Pancreatitis II: Collaborative Care
388
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
388


